XML 22 R5.htm IDEA: XBRL DOCUMENT v3.21.2
Consolidated Statements of Shareholders' Equity - USD ($)
$ in Thousands
Total
Common stock
Additional paid-in capital
Treasury stock
Retained earnings
Retained earnings
Cumulative Effect, Period of Adoption, Adjustment
Accumulated other comprehensive loss
Cumulative effect adjustment for adoption of new accounting pronouncements (1) [1]           $ 7,815  
Beginning of period (in shares) at Sep. 29, 2018   31,838,000          
Exercise of stock options and vesting of other share-based awards   350,000          
Treasury shares purchased (in shares)   (3,184,000)          
End of period (in shares) at Sep. 28, 2019   29,004,000          
Beginning of period at Sep. 29, 2018 $ 921,143 $ 526 $ 581,488 $ (711,138) $ 1,062,246   $ (11,979)
Exercise of stock options and vesting of other share-based awards   3          
Share-based compensation expense     21,335        
Exercise of stock options and vesting of other share-based awards, including tax withholding     (5,422)        
Treasury shares purchased       (182,109)      
Net income 108,616       108,616    
Other comprehensive income (loss) (5,805)           (5,805)
End of period at Sep. 28, 2019 $ 865,576 $ 529 597,401 (893,247) 1,178,677   (17,784)
Cumulative effect adjustment for adoption of new accounting pronouncements (1) [1]           $ (1,077)  
Exercise of stock options and vesting of other share-based awards   608,000          
Treasury shares purchased (in shares)   (610,000)          
End of period (in shares) at Oct. 03, 2020 29,002,000 29,002,000          
Exercise of stock options and vesting of other share-based awards   $ 6          
Share-based compensation expense     24,280        
Exercise of stock options and vesting of other share-based awards, including tax withholding     (117)        
Treasury shares purchased       (41,392)      
Net income $ 117,479       117,479    
Other comprehensive income (loss) 12,725           12,725
End of period at Oct. 03, 2020 $ 977,480 $ 535 621,564 (934,639) 1,295,079   (5,059)
Exercise of stock options and vesting of other share-based awards   323,000          
Treasury shares purchased (in shares)   (1,278,000)          
End of period (in shares) at Oct. 02, 2021 28,047,000 28,047,000          
Exercise of stock options and vesting of other share-based awards   $ 3          
Share-based compensation expense     24,326        
Exercise of stock options and vesting of other share-based awards, including tax withholding     (6,112)        
Treasury shares purchased       (108,452)      
Net income $ 138,912       138,912    
Other comprehensive income (loss) 2,075           2,075
End of period at Oct. 02, 2021 $ 1,028,232 $ 538 $ 639,778 $ (1,043,091) $ 1,433,991   $ (2,984)
[1] See Note 1, "Description of Business and Significant Accounting Policies," for a discussion of recently adopted accounting pronouncements.